Total synthesis of azinomycin A

Angewandte Chemie - International Edition

Volumn 40, Issue 9, 2001, Pages 1736-1739

  Coleman, Robert S ^a   Li, Jing ^a   Navarro, Antonio ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antitumor agents; Asymmetric synthesis; Natural products; Peptides; Total synthesis

Indexed keywords

ORGANIC COMPOUNDS; SYNTHESIS (CHEMICAL); TUMORS;

ANTITUMOR AGENTS;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; AZINOMYCIN A; AZINOMYCIN B; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0035805308     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. a) K. Nagaoka, M. Matsumoto, J. Oono, K. Yokoi, S. Ishizeki, T. Nakashima, J. Antibiot. 1986, 39, 1527;
2. b) K. Yokoi, K. Nagaoka, T. Nakashima, Chem. Pharm. Bull. 1986, 34, 4554. Azinomycin B (2) is apparently identical to carzinophilin A, an antitumor agent isolated in 1954 from Streptomyces sahachiroi: T. Hata, F. Koga, Y. Sano, K. Kanamori, A. Matsumae, R. Sugawara, T. Hoshi, T. Shimi, S. Ito, S. Tomizawa, J. Antibiot. Ser. A 1954, 7, 107.
3. b) K. Yokoi, K. Nagaoka, T. Nakashima, Chem. Pharm. Bull. 1986, 34, 4554. Azinomycin B (2) is apparently identical to carzinophilin A, an antitumor agent isolated in 1954 from Streptomyces sahachiroi: T. Hata, F. Koga, Y. Sano, K. Kanamori, A. Matsumae, R. Sugawara, T. Hoshi, T. Shimi, S. Ito, S. Tomizawa, J. Antibiot. Ser. A 1954, 7, 107.
4. a) J. A. Hartley, A. Hazrati, L. R. Kelland, R. Khanim, M. Shipman, F. Suzenet, L. F. Walker, Angew. Chem. 2000, 112, 3609; Angew. Chem. Int. Ed. 2000, 39, 3467;
5. a) J. A. Hartley, A. Hazrati, L. R. Kelland, R. Khanim, M. Shipman, F. Suzenet, L. F. Walker, Angew. Chem. 2000, 112, 3609; Angew. Chem. Int. Ed. 2000, 39, 3467;
6. b) J. A. Hartley, A. Hazrati, T. J. Hodgkinson, L. R. Kelland, R. Khanim, M. Shipman, F. Suzenet, Chem. Commun. 2000, 2325;
7. c) T.J. Hodgkinson, L. R. Kelland, M. Shipman, F. Suzenet, Bioorg. Med. Chem. Lett. 2000, 10, 239.
8. a) H. J. Bryant, C. Y. Dardonville, T. J. Hodgkinson, M. Shipman, A. M. Z. Slawin, Synlett 1996, 973;
9. b) H. J. Bryant, C. Y. Dardonville, T. J. Hodgkinson, M. H. Hursthouse, K. M. A. Malik, M. Shipman, J. Chem. Soc. Perkin Trans. I 1998, 1249;
10. c) R. W. Armstrong, J. E. Tellew, E. J. Moran, Tetrahedron Lett. 1996, 37, 447;
11. d) E. J. Moran, J. E. Tellew, Z. Zhao, R. W. Armstrong, J. Org. Chem. 1993, 58, 7848;
12. e) R. W. Armstrong, E. J. Moran, J. Am. Chem. Soc. 1992, 114, 371;
13. f) A. P. Combs, R. W. Armstrong, Tetrahedron Lett. 1992, 33, 6419;
14. g) R. W. Armstrong, J. E. Tellew, E. J. Moran, J. Org. Chem. 1992, 57, 2208;
15. h) E. J. Moran, R. W. Armstrong, Tetrahedron Lett. 1991, 32, 3807;
16. i) P. England, K. H. Chun, E. J. Moran, R. W. Armstrong, Tetrahedron Lett. 1990, 31, 2669;
17. j) M. Hashimoto, S. Terashima, Heterocycles 1998, 47, 59;
18. k) M. Hashimoto, S. Terashima, Tetrahedron Lett. 1994, 35, 9409;
19. l) M. Hashimoto, S. Terashima, Chem. Lett. 1994, 6, 1001;
20. m) M. Hashimoto, M. Matsumoto, K. Yamada, S. Terashima, Tetrahedron Lett. 1994, 35, 2207;
21. n) M. Hashimoto, K. Yamada, S. Terashima, Chem. Lett. 1992, 6, 975;
22. o) Y. Konda, T. Machida, T. Sasaki, K. Takeda, H. Takayanagi, Y. Harigaya, Chem. Pharm. Bull. 1994, 42, 285;
23. p) K. Ando, T. Yamada, M. Shibuya, Heterocycles 1989, 29, 2209;
24. q) K. Shishido, T. Omodani, M. Shibuya, J. Chem. Soc. Perkin Trans. I 1992, 2053;
25. r) M. Shibuya, H. Terauchi, Tetrahedron Lett. 1987, 28, 2619;
26. s) M. Shibuya, Tetrahedron Lett. 1983, 24, 1175.
27. 1 against P388 leukemia.
28. K. S. Gates in Comprehensive Natural Products Chemistry, Vol. 7 (Eds.: D. Barton, K. Nakanishi, O. Meth-Cohn), Pergamon, 1999, pp. 491-552.
29. For a review on DNA cross-linking agents, see: S. R. Rajski, R. M. Williams, Chem. Rev. 1998, 98, 2723.
30. a) S. Alcaro, R. S. Coleman, J. Med. Chem. 2000, 43, 2783;
31. b) S. Alcaro, R. S. Coleman, J. Org. Chem. 1998, 63, 4620.
32. a) H. Zang, K. S. Gates, Biochemistry 2000, 39, 14968;
33. b) T. Fujiwara, I. Saito, H. Sugiyama, Tetrahedron Lett. 1999, 40, 315;
34. c) R. W. Armstrong, M. E. Salvati, M. Nguyen, J. Am. Chem. Soc. 1992, 114, 3144;
35. d) J. W. Lown, K. C. Majumdar, Can. J. Biochem. 1977, 55, 630.
36. a) R. S. Coleman, C. R. Sarko, J. P. Gittinger, Tetrahedron Lett. 1997, 38, 5917;
37. b) R. S. Coleman, J. D. McKinley, Tetrahedron Lett. 1998, 39, 3433.
38. a) U. Schmidt, A. Lieberknecht, J. Wild, Synthesis 1984, 53;
39. b) U. Zoller, D. Ben-Ishai, Tetrahedron 1975, 31, 863.
40. a) R. S. Coleman, J.-S. Kong, T. E. Richardson, J. Am. Chem. Soc. 1999, 121, 9088;
41. b) R. S. Coleman, T. E. Richardson, A. J. Carpenter, J. Org. Chem. 1998, 63, 5738;
42. c) R. S. Coleman, J.-S. Kong, J. Am. Chem. Soc. 1998, 120, 3538.
43. R. S. Coleman, A. J. Carpenter, J. Org. Chem. 1992, 57, 5813.
44. a) R. S. Coleman, Synlett 1998, 1031;
45. b) R. S. Coleman, A. J. Carpenter, Tetrahedron 1997, 53, 16313.
46. A. Lieberknecht, J. Schmidt, J. J. Stezowski, Tetrahedron Lett. 1991, 32, 2113.
47. H. C. Brown, P. K. Jadhav, K. S. Bhat, J. Am. Chem. Soc. 1988, 110, 1535.
48. R. S. Coleman, A. J. Carpenter, J. Org. Chem. 1993, 58, 4452. For the topic of "working models that do not work", see chapter 2 in: M. A. Sierra, M. C. de la Torre, Angew. Chem. 2000, 112, 1628-1650; Angew. Chem. Int. Ed. 2000, 39, 1538-1559.
49. R. S. Coleman, A. J. Carpenter, J. Org. Chem. 1993, 58, 4452. For the topic of "working models that do not work", see chapter 2 in: M. A. Sierra, M. C. de la Torre, Angew. Chem. 2000, 112, 1628-1650; Angew. Chem. Int. Ed. 2000, 39, 1538-1559.
50. R. S. Coleman, A. J. Carpenter, J. Org. Chem. 1993, 58, 4452. For the topic of "working models that do not work", see chapter 2 in: M. A. Sierra, M. C. de la Torre, Angew. Chem. 2000, 112, 1628-1650; Angew. Chem. Int. Ed. 2000, 39, 1538-1559.
51. 12SiBr + Na: 946.2558).
52. In a variety of model systems related to 20 and 1, the C13-H consistently resonates upfield in the (E)-isomer, whereas the N 16-H resonates downfield in this isomer: see ref. [13b].
53. L. Birkofer, E. Bierwirth, A. Ritter, Chem Ber. 1961, 94, 821. See also: M. Sakaitani, Y. Ohfune, J. Org. Chem. 1990, 55, 870.
54. L. Birkofer, E. Bierwirth, A. Ritter, Chem Ber. 1961, 94, 821. See also: M. Sakaitani, Y. Ohfune, J. Org. Chem. 1990, 55, 870.
55. R. S. Coleman, J. A. Shah, Synthesis 1999, 1399.
56. 10Si + Na: 732.2928).
57. B. L. Gaffney, R. A. Jones, Tetrahedron Lett. 1982, 23, 2257.
58. 10 + H: 596.2244).
59. Model systems for the azabicyclic system of the natural products also exhibited instability when the C12-hydroxy protecting group was removed. In simple systems, deprotection of a trimethylsilyl ether was run in situ in an NMR tube because the product could not be isolated. For details, see ref. [11].
60. R. J. Perez, unpublished observations from this lab.